Resultats de la cerca - Boland, M.R.
- Mostrar 1 - 8 resultats de 8
-
1
-
2
-
3
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis per Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Publicat 2021Text -
4
-
5
Incidental Phaeochromocytoma on Staging PET-CT in a Patient with a Sigmoid Tumour and Situs Inversalis Totalis per Boland, M. R., Lowery, A. J., Walsh, S., Beddy, D., Prichard, R. S., O'Shea, D., Skehan, S. J., McDermott, E. W.
Publicat 2014Text -
6
-
7
Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy per Boland, M. R., McVeigh, T. P., O'Flaherty, N., Gullo, G., Keane, M., Quinn, C. M., McDermott, E. W., Lowery, A. J., Kerin, M. J., Prichard, R. S.
Publicat 2017Text -
8
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer per Davey, M G, Ryan, É J, Folan, P J, O’Halloran, N, Boland, M R, Barry, M K, Sweeney, K J, Malone, C M, McLaughlin, R J, Kerin, M J, Lowery, A J
Publicat 2021Text